Pugh RP - Search Results

1

Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.

Jones DV Jr, Winn RJ, Brown BW, Levy LB, Pugh RP, Wade JL 3rd, Gross HM, Pendergrass KB, Levin B, Abbruzzese JL. Jones DV Jr, et al. Among authors: pugh rp. Cancer. 1995 Nov 15;76(10):1709-14. doi: 10.1002/1097-0142(19951115)76:10<1709::aid-cncr2820761006>3.0.co;2-5. Cancer. 1995. PMID: 8625038 Clinical Trial.

2

ViVACCy--a drug schedule based on G2 blockade and prolonged infusion of multiple tubulin-binding agents. A pilot study.

Shackney SE, Pugh RP, Zidar BL, Raju RN, Simon SR, Mazur RN, Mucenski JW. Shackney SE, et al. Among authors: pugh rp. Cancer. 1990 Aug 1;66(3):411-7. doi: 10.1002/1097-0142(19900801)66:3<411::aid-cncr2820660302>3.0.co;2-7. Cancer. 1990. PMID: 2194639 Clinical Trial.

3

A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: a Southwest Oncology Group study.

Brown TD, Fleming TR, Goodman PJ, Macdonald JS, Pugh RP, O'Rourke T. Brown TD, et al. Among authors: pugh rp. Anticancer Drugs. 1995 Apr;6(2):219-23. doi: 10.1097/00001813-199504000-00004. Anticancer Drugs. 1995. PMID: 7795270 Clinical Trial.

4

Treatment of advanced breast carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.

Chlebowski RT, Pugh RP, Weiner JM, Bateman JR. Chlebowski RT, et al. Among authors: pugh rp. Cancer. 1981 Oct 15;48(8):1711-4. doi: 10.1002/1097-0142(19811015)48:8<1711::aid-cncr2820480804>3.0.co;2-c. Cancer. 1981. PMID: 7284972 Clinical Trial.

5

Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial.

Chlebowski RT, Pugh R, Weiner JM, Block JB, Bateman JR. Chlebowski RT, et al. Cancer. 1983 Aug 15;52(4):606-9. doi: 10.1002/1097-0142(19830815)52:4<606::aid-cncr2820520405>3.0.co;2-s. Cancer. 1983. PMID: 6344982 Clinical Trial.

6

Treatment of six cases of mesothelioma with doxorubicin and cisplatin.

Zidar BL, Pugh RP, Schiffer LM, Raju RN, Vaidya KA, Bloom RL, Horne D, Baker LH. Zidar BL, et al. Among authors: pugh rp. Cancer. 1983 Nov 15;52(10):1788-91. doi: 10.1002/1097-0142(19831115)52:10<1788::aid-cncr2820521005>3.0.co;2-#. Cancer. 1983. PMID: 6684983

7

Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy.

Chlebowski RT, Irwin LE, Pugh RP, Sadoff L, Hestorff R, Wiener JM, Bateman JR. Chlebowski RT, et al. Among authors: pugh rp. Cancer Res. 1979 Nov;39(11):4503-6. Cancer Res. 1979. PMID: 387216 Clinical Trial.

8

Treatment of advanced gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.

Chlebowski RT, Paroly WS, Pugh RP, Weiner JM, Bateman JR. Chlebowski RT, et al. Among authors: pugh rp. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1979-81. Cancer Treat Rep. 1979. PMID: 393383 Clinical Trial.

9

Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).

Jacobs EM, Reeves WJ Jr, Wood DA, Pugh R, Braunwald J, Bateman JR. Jacobs EM, et al. Cancer. 1971 Jun;27(6):1302-5. doi: 10.1002/1097-0142(197106)27:6<1302::aid-cncr2820270604>3.0.co;2-5. Cancer. 1971. PMID: 5088208 No abstract available.

10

Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.

Irwin LE, Chlebowski RT, Weiner JM, Reynolds R, Pugh RP, Ryden VM, Bateman JR. Irwin LE, et al. Among authors: pugh rp. Cancer Treat Rep. 1980 Aug-Sep;64(8-9):981-4. Cancer Treat Rep. 1980. PMID: 7004635 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page